Precision oncology informatics for anticancer drug combination responses: A systematic review
Abstract
Drug combination therapy against cancer has been a promising approach in precision oncology. In recent literature, most anticancer drug combinations (ADC) are estimated and derived from their independent drug response efficacy. Synergistic drug combination response is the most effective drug therapy for various cancer treatments. However, the ADC identification problem is challenging and practically infeasible to exhaustively screen out experimentally from the extensive ADCs. Therefore, computational approaches can be efficiently used to measure and identify drug combination responses in precision oncology. In recent decades, numerous computational approaches have been applied and proposed to predict the responses of clinical ADC using different pharmacological and multi-omics cancer data. Effective computational tools and approaches are needed to predict and measure ADC, address its challenges, and reduce complexity. We have reviewed state-of-the-art computational methods for ADC prediction in the recent decade. This review paper has provided an overview of synergistic ADC response and computational machine-learning approaches for ADC. A critical discussion of the advantages and limitations is also provided. Moreover, we have reviewed the recent existing drug combination resources for ADC response prediction and found the most influential computational method for anticancer drug combination response. Finally, we have compared different computational approaches using…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2)
- In silico and in vitro studies: investigating the chemical composition, DFT, molecular docking, and dynamic simulation of Satureja candidissima (Munby) Briq essential oil as a potential antibacterial agent
- Quercetin combined with ciprofloxacin and gentamicin inhibits biofilm formation and virulence in Staphylococcus aureus
- In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs
- Anticonvulsant Effects of Citronellal, Daidzin, and Phytol, Possibly Through GABAA Receptor and Voltage-Gated Sodium Channel Interaction Pathways: In Vivo and In Silico Studies
- 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as D3R-Selective Ligands for 3D-QSAR, Docking and Molecular Dynamics Simulation Studies
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.